Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marta Romano

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
Plos One|April 12, 2014
The influence of sex steroid hormones in the immunopathology of experimental pulmonary tuberculosisEstela Isabel Bini, Dulce Mata Espinosa, Brenda Marquina Castillo, et al.
Frontiers in Immunology|August 28, 2018
Allergic Asthma Favors <i>Brucella</i> Growth in the Lungs of Infected MiceArnaud Machelart, Georges Potemberg, Laurye Van Maele, et al.
Plos One|October 22, 2020
DNA damage and health effects in juvenile haddock (Melanogrammus aeglefinus) exposed to PAHs associated with oil-polluted sediment or produced waterSonnich Meier, Ørjan Karlsen, Jeremie Le Goff, et al.
Journal of Innate Immunity|November 18, 2016
Inflammatory Properties and Adjuvant Potential of Synthetic Glycolipids Homologous to Mycolate Esters of the Cell Wall of Mycobacterium tuberculosisHermann Giresse Tima, Juma''a Raheem Al Dulayymi, Olivier Denis, et al.
ACS Infectious Diseases|August 18, 2025
Long-Term Neuroimaging Findings in a Murine Model of Human Extraparenchymal NeurocysticercosisAlejandro Méndez, Agnes Fleury, Roger Carrillo-Mezo, et al.
Plos One|May 3, 2011
Experimental tuberculosis in the Wistar rat: a model for protective immunity and control of infectionAmit Singhal, El Moukhtar Aliouat, Maxime Hervé, et al.
The Lancet. Respiratory Medicine|March 2, 2015
Safety, immunogenicity, and efficacy of the candidate tuberculosis vaccine MVA85A in healthy adults infected with HIV-1: a randomised, placebo-controlled, phase 2 trialBirahim Pierre Ndiaye, Friedrich Thienemann, Martin Ota, et al.
Trials|November 28, 2020
A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trialTimothy Devos, Tatjana Geukens, Alexander Schauwvlieghe, et al.
The European Respiratory Journal|August 27, 2021
Early high antibody titre convalescent plasma for hospitalised COVID-19 patients: DAWn-plasmaTimothy Devos, Quentin Van Thillo, Veerle Compernolle, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|July 9, 2021
SARS-CoV-2 neutralising antibody testing in Europe: towards harmonisation of neutralising antibody titres for better use of convalescent plasma and comparability of trial dataDung Nguyen, Peter Simmonds, Maurice Steenhuis, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Plos One|April 12, 2014
The influence of sex steroid hormones in the immunopathology of experimental pulmonary tuberculosisEstela Isabel Bini, Dulce Mata Espinosa, Brenda Marquina Castillo, et al.
Frontiers in Immunology|August 28, 2018
Allergic Asthma Favors <i>Brucella</i> Growth in the Lungs of Infected MiceArnaud Machelart, Georges Potemberg, Laurye Van Maele, et al.
Plos One|October 22, 2020
DNA damage and health effects in juvenile haddock (Melanogrammus aeglefinus) exposed to PAHs associated with oil-polluted sediment or produced waterSonnich Meier, Ørjan Karlsen, Jeremie Le Goff, et al.
Journal of Innate Immunity|November 18, 2016
Inflammatory Properties and Adjuvant Potential of Synthetic Glycolipids Homologous to Mycolate Esters of the Cell Wall of Mycobacterium tuberculosisHermann Giresse Tima, Juma''a Raheem Al Dulayymi, Olivier Denis, et al.
ACS Infectious Diseases|August 18, 2025
Long-Term Neuroimaging Findings in a Murine Model of Human Extraparenchymal NeurocysticercosisAlejandro Méndez, Agnes Fleury, Roger Carrillo-Mezo, et al.
Plos One|May 3, 2011
Experimental tuberculosis in the Wistar rat: a model for protective immunity and control of infectionAmit Singhal, El Moukhtar Aliouat, Maxime Hervé, et al.
The Lancet. Respiratory Medicine|March 2, 2015
Safety, immunogenicity, and efficacy of the candidate tuberculosis vaccine MVA85A in healthy adults infected with HIV-1: a randomised, placebo-controlled, phase 2 trialBirahim Pierre Ndiaye, Friedrich Thienemann, Martin Ota, et al.
Trials|November 28, 2020
A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trialTimothy Devos, Tatjana Geukens, Alexander Schauwvlieghe, et al.
The European Respiratory Journal|August 27, 2021
Early high antibody titre convalescent plasma for hospitalised COVID-19 patients: DAWn-plasmaTimothy Devos, Quentin Van Thillo, Veerle Compernolle, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|July 9, 2021
SARS-CoV-2 neutralising antibody testing in Europe: towards harmonisation of neutralising antibody titres for better use of convalescent plasma and comparability of trial dataDung Nguyen, Peter Simmonds, Maurice Steenhuis, et al.
Pageof 9